These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34911791)

  • 1. Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction.
    Carnicelli AP; Owen R; Pocock SJ; Brieger DB; Yasuda S; Nicolau JC; Goodman SG; Cohen MG; Simon T; Westermann D; Hedman K; Andersson Sundell K; Granger CB
    Open Heart; 2021 Dec; 8(2):. PubMed ID: 34911791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study.
    Westermann D; Goodman SG; Nicolau JC; Requena G; Maguire A; Chen JY; Granger CB; Grieve R; Pocock SJ; Blankenberg S; Vega AM; Yasuda S; Simon T; Brieger D;
    Clin Cardiol; 2017 Dec; 40(12):1197-1204. PubMed ID: 29247524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.
    Zeymer U; Annemans L; Danchin N; Pocock S; Newsome S; Van de Werf F; Medina J; Bueno H
    Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):121-129. PubMed ID: 29611427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).
    Fox KAA; Accetta G; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Kayani G; Kakkar AK;
    Eur Heart J Qual Care Clin Outcomes; 2018 Jan; 4(1):27-35. PubMed ID: 28950344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life 1-3 years post-myocardial infarction: its impact on prognosis.
    Pocock S; Brieger DB; Owen R; Chen J; Cohen MG; Goodman S; Granger CB; Nicolau JC; Simon T; Westermann D; Yasuda S; Hedman K; Mellström C; Andersson Sundell K; Grieve R
    Open Heart; 2021 Feb; 8(1):. PubMed ID: 33563776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry.
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli G; Reiffel J; Singer DE; Peterson ED; Piccini JP;
    J Am Coll Cardiol; 2016 Dec; 68(24):2597-2604. PubMed ID: 27978942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quality of warfarin therapy and CHA2DS2-VASc score associate with the incidence of myocardial infarction and cardiovascular outcome in patients with atrial fibrillation: data from the nationwide FinWAF Registry.
    Raatikainen MJP; Penttilä T; Korhonen P; Mehtälä J; Lassila R; Lehto M
    Eur Heart J Cardiovasc Pharmacother; 2018 Oct; 4(4):211-219. PubMed ID: 29514184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Atrial FibriLlatiOn (FLOW-AF) Registry in the Middle East and North Africa: Patient Characteristics, Treatment Patterns and Outcomes.
    Almahmeed WA; Hersi A; Khalife N; Gamaleldin MFS; Kherraf SA; Sobhy MA; Lopes RD; Khoury M
    Adv Ther; 2024 Jul; 41(7):2868-2889. PubMed ID: 38802637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
    De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P
    Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction.
    Madsen JM; Jacobsen MR; Sabbah M; Topal DG; Jabbari R; Glinge C; Køber L; Torp-Pedersen C; Pedersen F; Sørensen R; Holmvang L; Engstrøm T; Lønborg JT
    Am Heart J; 2021 Aug; 238():89-99. PubMed ID: 33957102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry.
    Bertomeu-Gonzalez V; Moreno-Arribas J; Esteve-Pastor MA; Roldán-Rabadán I; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
    J Am Heart Assoc; 2020 Jan; 9(1):e013789. PubMed ID: 31870235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP
    Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry.
    Dai Y; Yang J; Gao Z; Xu H; Sun Y; Wu Y; Gao X; Li W; Wang Y; Gao R; Yang Y;
    BMC Cardiovasc Disord; 2017 Jan; 17(1):2. PubMed ID: 28052755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohort profile: patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation-Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF).
    Ikemura N; Spertus JA; Kimura T; Mahaffey K; Piccini JP; Inohara T; Ueda I; Tanimoto K; Suzuki M; Nakamura I; Akaishi M; Mitamura H; Fukuda K; Takatsuki S; Kohsaka S
    BMJ Open; 2019 Dec; 9(12):e032746. PubMed ID: 31857312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-Related Differences in the Clinical Characteristics and Treatment of Elderly Patients With Atrial Fibrillation in Japan　- Insight From the ANAFIE (All Nippon AF In Elderly) Registry.
    Hiasa KI; Kaku H; Inoue H; Yamashita T; Akao M; Atarashi H; Koretsune Y; Okumura K; Shimizu W; Ikeda T; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Tsutsui H
    Circ J; 2020 Feb; 84(3):388-396. PubMed ID: 31969518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry.
    Li YG; Miyazawa K; Wolff A; Zubaid M; Alsheikh-Ali AA; Sulaiman K; Lip GYH
    Int J Cardiol; 2019 Jan; 274():158-162. PubMed ID: 30291008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Atrial Fibrillation During Acute Myocardial Infarction May Not Be an Indication for Long-Term Anticoagulation.
    Axelrod M; Gilutz H; Plakht Y; Greenberg D; Novack L
    Angiology; 2020 Jul; 71(6):559-566. PubMed ID: 32103687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Marinkovic JM; Lip GY
    Int J Cardiol; 2013 Oct; 168(5):4744-9. PubMed ID: 23958417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Stenestrand U; Lindbäck J; Wallentin L;
    Circulation; 2005 Nov; 112(21):3225-31. PubMed ID: 16301355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.